                         SEQUENCE LISTING

<110>  Flow Pharma, Inc.
       Rubsamen, Reid
       Herst, Charles V.
       Wang, Lu
       Burkholz, Scott R.
       Carback, Richard T.
       Ciotios, Serban
 
<120>  Flow Pharma, Inc.

<130>  PHRM-007WO

<140>  PCT/US2020/020458
<141>  2020-02-28

<150>  US 62/812,723
<151>  2019-03-01

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  1

Ala Met Phe Pro Asn Ala Pro Tyr Leu 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  2

Ala Met Phe Pro Asn Ala Pro Tyr Pro 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  3

Arg Met Phe Pro Asn Ala Pro Tyr Leu 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  4

Arg Met Phe Pro Asn Ala Pro Tyr Pro 
1               5                   


<210>  5
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  5

Ala Lys Phe Val Ala Ala Trp Thr Leu Lys Ala Ala Ala 
1               5                   10              


<210>  6
<211>  140
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  6

Met Gly Ala Pro Ala Leu Pro Gln Ile Trp Gln Leu Tyr Leu Lys Asn 
1               5                   10                  15      


Tyr Arg Ile Ala Thr Phe Lys Asn Trp Pro Phe Leu Glu Asp Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asn Pro Ile Glu Glu His Arg Lys His 
65                  70                  75                  80  


Ser Pro Gly Cys Ala Phe Leu Thr Val Lys Lys Gln Met Glu Glu Leu 
                85                  90                  95      


Thr Val Ser Glu Phe Leu Lys Leu Asp Arg Gln Arg Ala Lys Asn Lys 
            100                 105                 110         


Ile Ala Lys Glu Thr Asn Asn Lys Gln Lys Glu Phe Glu Glu Thr Ala 
        115                 120                 125             


Lys Thr Thr Arg Gln Ser Ile Glu Gln Leu Ala Ala 
    130                 135                 140 


<210>  7
<211>  121
<212>  PRT
<213>  Artificial sequence

<220>
<223>  synthetic sequence

<400>  7

Met Gly Ala Pro Ala Leu Pro Gln Ile Trp Gln Leu Tyr Leu Lys Asn 
1               5                   10                  15      


Tyr Arg Ile Ala Thr Phe Lys Asn Trp Pro Phe Leu Glu Asp Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asn Pro Ile Glu Glu His Arg Lys His 
65                  70                  75                  80  


Ser Pro Gly Cys Ala Phe Leu Thr Val Lys Lys Gln Met Glu Glu Leu 
                85                  90                  95      


Thr Val Ser Glu Phe Leu Lys Leu Asp Arg Gln Arg Ala Lys Asn Lys 
            100                 105                 110         


Ile Val Cys Met Ile Glu Asn Lys Asp 
        115                 120     


